近期论文
查看导师新发文章
（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）
Chunming Tang, Cong Wang, Ying Zhang, Lingjing Xue, Yanyi Li , Caoyun Ju*, Can Zhang*. Recognition, Intervention, and Monitoring of Neutrophils in Acute Ischemic Stroke. Nano Letters, 2019,19(7), 4470-4477. (IF 12.279)
L Zhang#, Y Zhang#, YN Xue,Y Wu, QQ Wang, LJ Xue, ZG Su*, C Zhang*. Transforming Weakness into Strength Photothermal-Therapy-Induced Inflammation Enhanced Cytopharmaceutical Chemotherapy as a Combination Anticancer Treatment. Advanced Materials, 2019, 31(5), 1805936. (IF 21.950)
CY Ju#, Yj Wen#, LP Zhang, QQ Wang, LJ Xue, J Shen, C Zhang*. Neoadjuvant Chemotherapy Based on Abraxane/Human Neutrophils Cytopharmaceuticals with Radiotherapy for Gastric Cancer. Small, 2019, 15(5), 1804191. (IF 9.598)
MX Hao, SY Hou, LJ Xue, HL Yuan, LL Zhu, C Wang, B Wang, CM Tang, C Zhang*. Further Developments of the Phenyl-Pyrrolyl Pentane Series of Nonsteroidal Vitamin D Receptor Modulators as Anticancer Agents. J Med Chem. 2018, 61: 3059-75. （IF 6.253）
ZS Kang#, C Wang#, XL Han, JJ Du, YY Li, C Zhang*. Design, synthesis and biological evaluation of non-secosteriodal vitamin D receptor ligand bearing double side chain for the treatment of chronic pancreatitis. European Journal of Medicinal Chemistry, 2018, 146: 541-553. (IF: 4.816)
C Wang#, B Wang#, LJ Xue, ZS Kang, SY Hou, JJ Du, C Zhang*. Design, Synthesis and Antifibrosis Activity in Liver of Nonsecosteroidal Vitamin D Receptor Agonists with Phenyl-pyrrolyl Pentane Skeleton. Journal of Medicinal Chemistry, 2018. DOI: 10.1021/acs.jmedchem.8b01165. (IF: 6.253)
ZK Zhao, Y Zhang, CL Tian, TJ Yin*, C Zhang*. Facile dynamic one-step modular assembly based on boronic acid-diol for construction of a micellar drug delivery system. Biomaterial Sciences, 2018, 6(10): 2605-2618. (IF: 5.831)
Q Sun, CM Tang, ZG Su, JJ Du, YK Shang, LJ Xue, C Zhang*. A modular assembly pH-sensitive charge reversal siRNA delivery system. Biomaterials Science, DOI: 10.1039/c8bm01062e. (IF: 5.831)
ZS Kang#, C Wang#, XL Han, B Wang, HL Yuan, SY Hou, MX Hao, JJ Du, YY Li, AW Zhou, C Zhang*. Sulfonyl-containing phenyl-pyrrolyl pentane analogues: Novel non-secosteroidal vitamin D receptor modulators with favorable physicochemical properties, pharmacokinetic properties and anti-tumor activity. European Journal of Medicinal Chemistry, 2018, 157: 1174-1191. (IF: 4.816)
JW Xue, ZK Zhao, L Zhang, LJ Xue, SY Shen, YJ Wen, ZY Wei, L Wang, LY Kong, HB Sun, QN Ping, R Mo*, C Zhang*. Neutrophil-mediated anticancer drug delivery for suppression of postoperative malignant glioma recurrence. Nature Nanotechnology, 2017, 12(7): 692-700. (IF 38.986)
X Feng, W Yu, X Li, F Zhou, W Zhang, Q Shen, J Li, C Zhang*, P Shen*. Apigenin, a modulator of PPARγ, attenuates HFD-induced NAFLD by regulating hepatocyte lipid metabolism and oxidative stress via Nrf2 activation. Biochemical Pharmacology, 2017, 136:136-149. (IF 4.75)
T Cui, JJ Liang, H Chen, DD Geng, L Jiao, JY Yang, H Qian, C Zhang*, Y Ding*. Performance of Doxorubicin-Conjugated Gold Nanoparticles: Regulation of Drug Location. ACS Applied Materials & Interfaces, 2017, 9(10): 8569-8580. (IF: 7.504)
B Wang, MX Hao, C Zhang*. Design, synthesis and biological evaluation of nonsecosteroidal vitamin D3 receptor ligands as anti-tumor agents. Bioorganic & Medicinal Chemistry Letters, 2017, 27: 1428-1436. (IF: 2.454)
XY Chen, YD Zhang, CM Tang, CL Tian, Q Sun, ZG Su, LJ Xue, YF Yin, CY Ju*, C Zhang*. Co-delivery of paclitaxel and anti-survivin siRNA via redox-sensitive oligopeptide liposomes for the synergistic treatment of breast cancer and metastasis. International Journal of Pharmaceutics, 2017, 529(1-2): 102-115. (IF: 3.649)
YJ He, ZG Su, LJ Xue, H Xu*, C Zhang*. Co-delivery of erlotinib and doxorubicin by pH-sensitive charge conversion nanocarrier for synergistic therapy. J Control Release.2016. 229: 80-92. (IF: 7.705)
N Zhang, XF Xu, X Zhang, D Qu, LJ Xue*, R Mo, C Zhang*. Nanocomposite hydrogel incorporating gold nanorods and paclitaxel-loaded chitosan micelles for combination photothermal-chemotherapy. Int J Pharm. 2016, 497(1-2): 210-221. (IF: 3.65)
ZX Ge, MX Hao, M Xu, ZG Su, ZS Kang, LJ Xue**, C Zhang*. Novel nonsecosteroidal VDR ligands with phenyl-pyrrolyl pentane skeleton for cancer therapy. Eur J Med Chem. 2016, 107: 48-62. (IF: 3.447)
DB Yang, TF Wang, ZG Su*, LJ Xue, R Mo, C Zhang*. Reversing Cancer Multidrug Resistance in Xenograft Models via Orchestrating Multiple Actions of Functional Mesoporous Silica Nanoparticles. ACS Applied Materials & Interfaces 2016, 8 (34): 22431-22441. (IF: 7.504)
SY Yin, CM Tang, B Wang, Y Zhang, LL Zhou, LJ Xue*, C Zhang*. Design, synthesis and biological evaluation of novel EGFR/HER2 dual inhibitors bearing a oxazolo[4,5-g]quinazolin-2(1H)-one scaffold. European Journal of Medicinal Chemistry 2016, 120: 26-36. (IF: 3.902)
TF Wang, XF Liu, MX Hao, JN Qiao, CY Ju, LJ Xue*, C Zhang*. Design, synthesis and evaluation of pyrrolo[2,3-d]pyrimidine-phenylamide hybrids as potent Janus kinase 2 inhibitors. Bioorganic & Medicinal Chemistry Letters 2016, 26(12): 2936-2941. (IF: 2.486)
京公网安备 11010802027423号